Concepedia

Fengrui Zhou

FZ

6

Publications

255

Citations

6

H-Index

2016

Active since

Affiliations

Third Affiliated Hospital of Harbin Medical University(Current)

Harbin Medical University

Fengrui Zhou is an author at Third Affiliated Hospital of Harbin Medical University specializing in lung cancer, tumor biology, and cancer biology.

Top concepts

Publications per year

2016–2022

6

Publications

6

FAM83A signaling induces epithelial-mesenchymal transition by the PI3K/AKT/Snail pathway in NSCLC

Fengrui Zhou, Jianxiong Geng, Shanqi Xu et al. · Aging · 2019 · 90 citations · Full text

FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma

Fengrui Zhou, Xin Wang, Fang Liu et al. · International Journal of Clinical Oncology · 2020 · 65 citations

, , +9

TBL1XR1 is involved in c-Met-mediated tumorigenesis of human nonsmall cell lung cancer

Tiewa Zhang, Cheng Liu, Yan Yu et al. · Cancer Gene Therapy · 2019 · 31 citations

, , +9

CXCR1 correlates to poor outcomes of EGFR-TKI against advanced non-small cell lung cancer by activating chemokine and JAK/STAT pathway

Fang Yang, Shuai Zhang, Qingwei Meng et al. · Pulmonary Pharmacology & Therapeutics · 2021 · 31 citations

, , +8

The value of prognostic factors in Chinese patients with small cell lung cancer: A retrospective study of 999 patients

Xuan Hong, Qingyong Xu, Zhaoyang Yang et al. · The Clinical Respiratory Journal · 2016 · 28 citations

Rows per page

1–5 of 6